FDA Still Testing Imported Orange Juice for Carbendazim

The Food and Drug Administration has posted a question and answer document geared to consumers on Carbendazim and orange juice products. FDA explains it has received reports that low levels of the chemical carbendazim have been found in some orange juice products that contain imported orange juice concentrates. FDA believes that the levels of carbendazim are so low that there are no public health concerns. However, it is collecting and analyzing samples of orange juice products that arrive at U.S. borders from all countries and will not allow any that contain measurable levels of carbendazim to enter the U.S. It adds that Brazil and Mexico are the top two countries that ship orange juice concentrate to the U.S. and both allow carbendazim use; however, more than 75%of the orange juice sold in the U.S. is from oranges grown here. Additional FDA information available here.